Search

William P. Neuder

Examiner (ID: 10341)

Most Active Art Unit
3672
Art Unit(s)
3672, 2899, 3625, 3642, 3506
Total Applications
4583
Issued Applications
4090
Pending Applications
166
Abandoned Applications
332

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 16837989 [patent_doc_number] => 20210146001 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-05-20 [patent_title] => MEDICAL DRESSING MATERIAL HAVING CHITOSAN FABRIC SPONGE STRUCTURE AND METHOD OF MANUFACTURING SAME [patent_app_type] => utility [patent_app_number] => 17/048306 [patent_app_country] => US [patent_app_date] => 2019-04-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6719 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -20 [patent_words_short_claim] => 34 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17048306 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/048306
MEDICAL DRESSING MATERIAL HAVING CHITOSAN FABRIC SPONGE STRUCTURE AND METHOD OF MANUFACTURING SAME Apr 16, 2019 Abandoned
Array ( [id] => 16837805 [patent_doc_number] => 20210145817 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-05-20 [patent_title] => APIXABAN FORMULATIONS [patent_app_type] => utility [patent_app_number] => 17/047428 [patent_app_country] => US [patent_app_date] => 2019-04-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7349 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -28 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17047428 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/047428
Apixaban formulations Apr 14, 2019 Issued
Array ( [id] => 17241832 [patent_doc_number] => 20210361575 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-11-25 [patent_title] => LIPID PRODRUGS FOR USE IN DRUG DELIVERY [patent_app_type] => utility [patent_app_number] => 17/046270 [patent_app_country] => US [patent_app_date] => 2019-04-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 17522 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -99 [patent_words_short_claim] => 39 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17046270 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/046270
LIPID PRODRUGS FOR USE IN DRUG DELIVERY Apr 10, 2019 Abandoned
Array ( [id] => 16612028 [patent_doc_number] => 20210030681 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-02-04 [patent_title] => MULTIPARTICULATE SOLID DOSAGE FORM HAVING AN ELASTIC TEXTURE [patent_app_type] => utility [patent_app_number] => 17/046107 [patent_app_country] => US [patent_app_date] => 2019-04-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4879 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -12 [patent_words_short_claim] => 24 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17046107 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/046107
MULTIPARTICULATE SOLID DOSAGE FORM HAVING AN ELASTIC TEXTURE Apr 9, 2019 Abandoned
Array ( [id] => 14990897 [patent_doc_number] => 20190314406 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-10-17 [patent_title] => TRANSDERMAL MAGNESIUM CREAM COMPOSITIONS [patent_app_type] => utility [patent_app_number] => 16/371481 [patent_app_country] => US [patent_app_date] => 2019-04-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3919 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -33 [patent_words_short_claim] => 24 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16371481 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/371481
TRANSDERMAL MAGNESIUM CREAM COMPOSITIONS Mar 31, 2019 Abandoned
Array ( [id] => 16244770 [patent_doc_number] => 10744094 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2020-08-18 [patent_title] => Extended release pharmaceutical formulation [patent_app_type] => utility [patent_app_number] => 16/367855 [patent_app_country] => US [patent_app_date] => 2019-03-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 24 [patent_no_of_words] => 14991 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 456 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16367855 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/367855
Extended release pharmaceutical formulation Mar 27, 2019 Issued
Array ( [id] => 16518636 [patent_doc_number] => 10869838 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2020-12-22 [patent_title] => Extended release pharmaceutical formulation [patent_app_type] => utility [patent_app_number] => 16/362848 [patent_app_country] => US [patent_app_date] => 2019-03-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 25 [patent_no_of_words] => 22841 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 169 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16362848 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/362848
Extended release pharmaceutical formulation Mar 24, 2019 Issued
Array ( [id] => 19854536 [patent_doc_number] => 12257347 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2025-03-25 [patent_title] => Pharmaceutical composition comprising meta arsenite and method of manufacture [patent_app_type] => utility [patent_app_number] => 16/982399 [patent_app_country] => US [patent_app_date] => 2019-03-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 15416 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 493 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16982399 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/982399
Pharmaceutical composition comprising meta arsenite and method of manufacture Mar 20, 2019 Issued
Array ( [id] => 14563741 [patent_doc_number] => 20190209477 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-07-11 [patent_title] => Anticancer Compositions [patent_app_type] => utility [patent_app_number] => 16/357821 [patent_app_country] => US [patent_app_date] => 2019-03-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10921 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -46 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16357821 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/357821
Anticancer compositions Mar 18, 2019 Issued
Array ( [id] => 14563741 [patent_doc_number] => 20190209477 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-07-11 [patent_title] => Anticancer Compositions [patent_app_type] => utility [patent_app_number] => 16/357821 [patent_app_country] => US [patent_app_date] => 2019-03-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10921 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -46 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16357821 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/357821
Anticancer compositions Mar 18, 2019 Issued
Array ( [id] => 14563741 [patent_doc_number] => 20190209477 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-07-11 [patent_title] => Anticancer Compositions [patent_app_type] => utility [patent_app_number] => 16/357821 [patent_app_country] => US [patent_app_date] => 2019-03-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10921 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -46 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16357821 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/357821
Anticancer compositions Mar 18, 2019 Issued
Array ( [id] => 14563741 [patent_doc_number] => 20190209477 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-07-11 [patent_title] => Anticancer Compositions [patent_app_type] => utility [patent_app_number] => 16/357821 [patent_app_country] => US [patent_app_date] => 2019-03-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10921 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -46 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16357821 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/357821
Anticancer compositions Mar 18, 2019 Issued
Array ( [id] => 17241896 [patent_doc_number] => 20210361639 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-11-25 [patent_title] => SOLID COMPOSITIONS OF ACTIVES, PROCESSES FOR PREPARING SAME AND USES OF SUCH SOLID COMPOSITIONS [patent_app_type] => utility [patent_app_number] => 16/977435 [patent_app_country] => US [patent_app_date] => 2019-03-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 18539 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -27 [patent_words_short_claim] => 33 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16977435 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/977435
SOLID COMPOSITIONS OF ACTIVES, PROCESSES FOR PREPARING SAME AND USES OF SUCH SOLID COMPOSITIONS Mar 3, 2019 Abandoned
Array ( [id] => 14498149 [patent_doc_number] => 20190192729 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-06-27 [patent_title] => System and Method for Treating a Wound [patent_app_type] => utility [patent_app_number] => 16/285945 [patent_app_country] => US [patent_app_date] => 2019-02-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3738 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -10 [patent_words_short_claim] => 35 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16285945 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/285945
System and method for treating a wound Feb 25, 2019 Issued
Array ( [id] => 14464393 [patent_doc_number] => 20190183836 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-06-20 [patent_title] => MODIFIED RELEASE GAMMA- HYDROXYBUTYRATE FORMULATIONS HAVING IMPROVED PHARMACOKINETICS [patent_app_type] => utility [patent_app_number] => 16/281235 [patent_app_country] => US [patent_app_date] => 2019-02-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 48406 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -36 [patent_words_short_claim] => 99 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16281235 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/281235
Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics Feb 20, 2019 Issued
Array ( [id] => 16568971 [patent_doc_number] => 20210007977 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-01-14 [patent_title] => COMPOSITIONS AND METHODS OF AMELIORATING PHARMACEUTICAL AVERSIVENESS WITH SALTS [patent_app_type] => utility [patent_app_number] => 16/970733 [patent_app_country] => US [patent_app_date] => 2019-02-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5656 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16970733 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/970733
COMPOSITIONS AND METHODS OF AMELIORATING PHARMACEUTICAL AVERSIVENESS WITH SALTS Feb 17, 2019 Abandoned
Array ( [id] => 16452507 [patent_doc_number] => 20200361933 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-11-19 [patent_title] => PHARMACEUTICAL COMPOUND, SALTS THEREOF, FORMULATIONS THEREOF, AND METHODS OF MAKING AND USING SAME [patent_app_type] => utility [patent_app_number] => 16/966384 [patent_app_country] => US [patent_app_date] => 2019-02-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 20040 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -66 [patent_words_short_claim] => 8 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16966384 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/966384
PHARMACEUTICAL COMPOUND, SALTS THEREOF, FORMULATIONS THEREOF, AND METHODS OF MAKING AND USING SAME Jan 31, 2019 Abandoned
Array ( [id] => 18886459 [patent_doc_number] => 11865215 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2024-01-09 [patent_title] => Tablet compositions comprising abiraterone acetate [patent_app_type] => utility [patent_app_number] => 17/044698 [patent_app_country] => US [patent_app_date] => 2019-01-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 2933 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 133 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17044698 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/044698
Tablet compositions comprising abiraterone acetate Jan 24, 2019 Issued
Array ( [id] => 18186359 [patent_doc_number] => 11576917 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2023-02-14 [patent_title] => Pharmaceutical compositions comprising Ibrutinib [patent_app_type] => utility [patent_app_number] => 16/962907 [patent_app_country] => US [patent_app_date] => 2019-01-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3400 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 47 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16962907 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/962907
Pharmaceutical compositions comprising Ibrutinib Jan 10, 2019 Issued
Array ( [id] => 14273937 [patent_doc_number] => 20190134253 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-05-09 [patent_title] => WOUND MANAGEMENT SYSTEM AND METHODS OF USING [patent_app_type] => utility [patent_app_number] => 16/236944 [patent_app_country] => US [patent_app_date] => 2018-12-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4277 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -30 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16236944 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/236944
Wound management system and methods of using Dec 30, 2018 Issued
Menu